Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JK08 |
Trade Name | |
Synonyms | JK-08|JK 08 |
Drug Descriptions |
JK08 comprises an anti-CTLA4 antibody fused to the IL-15/IL15Ralpha complex, which may result in T-cell activation and an increased anti-tumor immune response (Ann Oncol (2023) 34 (suppl_2): S635, Journal for ImmunoTherapy of Cancer 2023;11). |
DrugClasses | CTLA4 Antibody 31 |
CAS Registry Number | NA |
NCIT ID | C198686 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JK08 | JK08 | 0 | 1 |